Aquestive Therapeutics Inc (NASDAQ:AQST)
| 7.14 Delayed Data As of Aug 14 |  +0.52 / +7.85%Today’s Change | 1.41 Today|||52-Week Range 10.00 | +22.68% Year-to-Date |
Latest AQST News | Press Releases
| Aquestive Therapeutics (AQST) Investor Presentation - Slideshow Aug 13 / Seeking Alpha - Paid Partner Content | Aquestive Therapeutics: Remains On The Track After Q2 Results Aug 12 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 6.62 |
| Today’s open | 6.75 |
| Day’s range | 6.70 - 7.33 |
| Volume | 31,259 |
| Average volume (3 months) | 965,939 |
| Market cap | $211.1M |
Data as of 3:59pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | +11.78% |
| Earnings growth (this year) | +41.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -21.98% |
| P/E ratio | NM |
| Price/Sales | 2.81 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CASICASI Pharmaceuticals... | -0.01 | -0.52% |
| UROVUrovant Sciences Ltd | -0.40 | -4.91% |
| LCILannett Company Inc | -0.13 | -2.11% |
| ABEOAbeona Therapeutics ... | -0.08 | -3.00% |
Data as of 4:00pm ET, 08/14/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $52.6M |
| Annual profit (last year) | -$66.2M |
| Net profit margin | -125.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
